Privia Health (PRVA Quick QuotePRVA - Free Report) reported $603.85 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 25.8%. EPS of $0.02 for the same period compares to $0.03 a year ago.

The reported revenue represents a surprise of +7.84% over the Zacks Consensus Estimate of $559.95 million. With the consensus EPS estimate being $0.08, the EPS surprise was -76.19%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Privia Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Practice Collections: $914.8 million compared to the $877.47 million average estimate based on four analysts.
• Care Margin: $128.7 million compared to the $121.29 million average estimate based on four analysts.
• Platform Contribution: $67 million versus the four-analyst average estimate of $60.57 million.
• Implemented Providers (as of end of period): 5,535 versus the three-analyst average estimate of 5,513.
• Value-Based Care Attributed Lives (as of end of period): 1.61 million compared to the 1.52 million average estimate based on three analysts.

View all Key Company Metrics for Privia Health here>>>

Shares of Privia Health have returned +5.6% over the past month versus the Zacks S&P 500 composite's +11.4% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.